Flavopiridol in Treating Patients With Recurrent Prostate Cancer
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of flavopiridol in treating patients with recurrent
prostate cancer after hormone therapy. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die.